19th Dec 2006 15:58
Dechra Pharmaceuticals PLC19 December 2006 Dechra Pharmaceuticals PLC Total Voting Rights In accordance with the Transparency Directive's transitional provision 6, DechraPharmaceuticals PLC ("Dechra Pharmaceuticals" or the "Company") is required to notify the market ofthe following: At the date of this announcement, Dechra Pharmaceuticals' capital consists of52,632,847 ordinary shares of 1 penny each, with voting rights. The Company doesnot hold any shares in Treasury. The above figure (52,632,847) may be used by shareholders as the denominator forthe calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in Dechra Pharmaceuticals underthe FSA's Disclosure and Transparency Rules. Stephen Whitehouse, Company Secretary, 19 December 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L